SciVision Biotech Inc.
TAI: 1786.TW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taiwan Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Tai Xian Han
- Employees
- 64
- Headquarters
- Kaohsiung, Taiwan
- IPO year
- 2013
- Market cap
- NT$4.3B
- Website
- https://www.scivision.com.tw
Loading 1786…
Loading profile data…Frequently asked questions about 1786
What does SciVision Biotech Inc. (1786.TW) do?
SciVision Biotech Inc. manufactures and sells hyaluronic acid products in Taiwan. It offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. The company was founded in 2001 and is based in Kaohsiung, Taiwan.
Where does 1786.TW trade?
SciVision Biotech Inc. (1786.TW) trades on the Taiwan Stock Exchange.
What sector is 1786.TW in?
SciVision Biotech Inc. (1786.TW) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of SciVision Biotech Inc.?
Tai Xian Han is the chief executive officer of SciVision Biotech Inc. (1786.TW).
Where is SciVision Biotech Inc. headquartered?
SciVision Biotech Inc. is headquartered in Taiwan.
Does 1786.TW pay a dividend?
Yes — SciVision Biotech Inc. (1786.TW) paid a trailing twelve-month dividend of TWD 1.91 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 1786.TW go public?
SciVision Biotech Inc. (1786.TW) completed its initial public offering in 2013.